Joe Rogan on pharmaceutical-advertising: what the evidence says · JRE #1880

What the evidence says 01 / RECORD

The claim has two parts. The assertion that the United States and New Zealand are the only two countries permitting direct-to-consumer (DTC) advertising of prescription drugs is well-supported: comparative research on DTC regulation consistently identifies the U.S. and New Zealand as the sole jurisdictions that allow product-claim DTC advertising, while most other countries, including Switzerland and the rest of the OECD, prohibit or tightly restrict it. The 75% figure for pharmaceutical companies' share of all television advertising is not supported by industry ad-spend data. Ad-monitoring sources put pharmaceutical and over-the-counter drug brands at roughly 13-14% of total U.S. national linear TV ad spending in 2025, and a single-digit-to-teens share of total ad airtime/impressions in recent years, far below 75%. Pharma is nonetheless a disproportionately large TV advertiser relative to other single industries, and documented DTC ad spending for prescription drugs runs into the billions of dollars annually with television as the majority channel. Separately, content analyses of drug commercials have found a substantial proportion of claims in these ads to be potentially misleading, an issue distinct from the ad-volume statistic.